Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 0 | 1,147 | 243 | 107 | 15 |
| Cost of Goods | N/A | 107 | N/A | N/A | N/A |
| Gross Profit | N/A | 1,040 | 243 | 107 | 15 |
| Operating Expenses | 5,426 | 9,847 | 6,551 | 6,165 | 3,364 |
| Operating Income | -5,426 | -8,700 | -6,308 | -6,058 | -3,349 |
| Interest Expense | 1,281 | 1,278 | 1,170 | 342 | 12 |
| Other Income | 279 | 594 | 1,451 | 972 | 53 |
| Pre-tax Income | -6,428 | -9,384 | -6,027 | -5,428 | -3,308 |
| Net Income Continuous | -6,428 | -9,384 | -6,027 | -5,428 | -3,308 |
| Net Income Discontinuous | -507 | N/A | N/A | N/A | N/A |
| Net Income | $-6,935 | $-9,384 | $-6,027 | $-5,428 | $-3,308 |
| EPS Basic Total Ops | -3,250.00 | -4,500.00 | -2,937.50 | -3,062.50 | -4,500.00 |
| EPS Basic Continuous Ops | -3,000.00 | -4,475.73 | -2,929.82 | -3,072.36 | -4,483.84 |
| EPS Basic Discontinuous Ops | -250.00 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -3,250.00 | -4,500.00 | -2,937.50 | -3,062.50 | -4,500.00 |
| EPS Diluted Continuous Ops | -3,000.00 | -4,475.73 | -2,929.82 | -3,072.36 | -4,483.84 |
| EPS Diluted Discontinuous Ops | -250.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-4,528 | $-8,011 | $-5,681 | $-5,582 | $-3,064 |